Earl Sands, M.d.
Chief Medical Officer
Selecta Biosciences
Australia
Biography
Dr. Sands joined Selecta Biosciences, Inc. in 2015. He previously served as Chief Medical Officer of Targacept, Inc. (now part of Catalyst Biosciences), a biopharmaceutical company, where he was responsible for designing and implementing Targacept’s clinical trials as well as providing strategic and scientific input on intellectual property matters and in‑licensing opportunities. Prior to Targacept, Dr. Sands was the Chief Medical Officer of Plasma Surgical, Inc., a developer of surgical and therapeutic applications, where he was responsible for strategic integrated clinical development plans and execution.
Research Interest
Molecular Biology and Molecular Genetics
